ARCHIVES

Cancer Program Critic Epstein Invited To NCAB T Make Argument: “We’re Losing War In Cancer”

This article is from The Cancer Letter archive.

Vol. 18 No. 18 | May 1, 1992

Download PDF Visit The Full Archive

Related Articles

Bristol Stock Drops Amid New Setbacks, Deepening Firm’s Decline In Oncology

April 5, 2002

Cancer Organizations Continue Reform Lobbying: Target Issue Are Off-Label Drugs, Clinical Trials

March 26, 1993

UPCI Recruits Shin To Lead Head & Neck Cancer Program.

April 27, 2001

The Cancer Letter Wins Investigative Reporting Award

June 8, 2001

Bills Would Give FDA Authority to Approve Generic Biotech Drugs.

February 16, 2007

NCI Cooperative Group Clinical Trials Approved

June 26, 2009